Accent Microcell Ltd
Incorporated in 2001, Accent Microcell Ltd manufactures Pharmaceutical Excipients[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
-
General Updates
8 July 2025 - Trading approval received for 29.46 lakh shares allotted via rights issue at Rs.135 each.
-
Copy of Newspaper Publication
4 July 2025 - Published basis of allotment for Accent Microcell's rights issue in newspapers and website.
-
General Updates
2 July 2025 - Allotment of 29.46 lakh shares at Rs.135 each via rights issue, increasing paid-up capital to 2.39 crore shares.
-
General Updates
27 June 2025 - Rights Issue of 29.46 lakh shares at Rs.135 closed on June 27, 2025, after NSE trading approval.
-
General Updates
16 June 2025 - NSE approves trading of 29.46 lakh rights shares at Rs.135 each, raising Rs.39.77 crore.
Annual reports
Concalls
-
May 2025Transcript PPT REC
-
Jan 2025TranscriptNotesPPTREC
-
Mar 2024TranscriptNotesPPTREC
Business Overview:[1]
AMC is an EXCiPACT, US-DMF, GMP, ISO 9001:2008, HACCP certified manufacturer and exporter of 22 different grades of Microcrystalline Cellulose (MCC). It caters to 10+ sectors and services 200+ customers in India and worldwide.